Haydee Artaza

Haydee Artaza

Auto-generated profile, based on publicly available information

Haydee Artaza

Department of Clinical Science, University of Bergen, Bergen, Norway

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2015 in RNA
Verified
Journal Article
Open access
PDF file
JGJesús García-López
Jesús García-López
LALola Alonso
Lola Alonso
DCDavid B. Cárdenas
David B. Cárdenas
HAHaydeé Artaza-Alvarez
Haydeé Artaza-Alvarez
JHJuan de Dios Hourcade
Juan de Dios Hourcade
JMJesús Del Mazo
Jesús Del Mazo
The small noncoding RNAs (sncRNAs) are considered as post-transcriptional key regulators of male germ cell development. In addition to microRNAs (miRNAs) and PIWI-interacting RNAs (piRNAs), other sncRNAs generated from small nucleolar RNAs (snoRNAs), tRNAs, or rRNAs processing may also play important regulatory roles in spermatogenesis. By next-generation sequencing (NGS), we characterized the sncRNA populations detected at three milestone stages in male germ differentiation: primordial germ cells (PGCs), pubertal spermatogonia cells, and mature spermatozoa. To assess their potential transmission through the spermatozoa during fertilization, the sncRNAs of mouse oocytes and zygotes were also analyzed. Both, microRNAs and snoRNA-derived small RNAs are abundantly expressed in PGCs but transiently replaced by piRNAs in spermatozoa and endo-siRNAs in oocytes and zygotes. Exhaustive analysis of miRNA sequence variants also shows an increment of noncanonical microRNA forms along male germ cell differentiation. RNAs-derived from tRNAs and rRNAs interacting with PIWI proteins are not generated by the ping-pong pathway and could be a source of primary piRNAs. Moreover, our results strongly suggest that the small RNAs-derived from tRNAs and rRNAs are interacting with PIWI proteins, and specifically with MILI. Finally, computational analysis revealed their potential involvement in post-transcriptional regulation of mRNA transcripts suggesting functional convergence among different small RNA classes in germ cells and zygotes.

11 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
DEDaniel Eriksson
Daniel Eriksson
EREllen Christine Røyrvik
Ellen Christine Røyrvik
MAMaribel Aranda-Guillén
Maribel Aranda-Guillén
ABAmund Holte Berger
Amund Holte Berger
NLNils Landegren
Nils Landegren
EHEystein Sverre Husebye
Eystein Sverre Husebye
Autoimmune Addison’s disease (AAD) is characterized by the autoimmune destruction of the adrenal cortex. Low prevalence and complex inheritance have long hindered successful genetic studies. We here report the first genome-wide association study on AAD, which identifies nine independent risk loci (P < 5 × 10−8). In addition to loci implicated in lymphocyte function and development shared with other autoimmune diseases such as HLA, BACH2, PTPN22 and CTLA4, we associate two protein-coding alterations in Autoimmune Regulator (AIRE) with AAD. The strongest, p.R471C (rs74203920, OR = 3.4 (2.7–4.3), P = 9.0 × 10−25) introduces an additional cysteine residue in the zinc-finger motif of the second PHD domain of the AIRE protein. This unbiased elucidation of the genetic contribution to development of AAD points to the importance of central immunological tolerance, and explains 35–41% of heritability (h2).

16 July 2018 in Molecular Plant Pathology
Verified
Journal Article
Closed access
PDF file
VRVirginia Ruiz‐Ferrer
Virginia Ruiz‐Ferrer
JCJavier Cabrera
Javier Cabrera
IMIsabel Martinez‐Argudo
Isabel Martinez‐Argudo
HAHaydeé Artaza
Haydeé Artaza
CFCarmen Fenoll
Carmen Fenoll
CECarolina Escobar
Carolina Escobar

16 August 2016 in F1000Research
Verified
Journal Article
Open access
PDF file
HAHaydee Artaza
Haydee Artaza
NHNeil Chue Hong
Neil Chue Hong
MCManuel Corpas
Manuel Corpas
ACAngel Corpuz
Angel Corpuz
RHRob W.W. Hooft
Rob W.W. Hooft
DVDaniel Vaughan
Daniel Vaughan
Metrics for assessing adoption of good development practices are a useful way to ensure that software is sustainable, reusable and functional. Sustainability means that the software used today will be available - and continue to be improved and supported - in the future. We report here an initial set of metrics that measure good practices in software development. This initiative differs from previously developed efforts in being a community-driven grassroots approach where experts from different organisations propose good software practices that have reasonable potential to be adopted by the communities they represent. We not only focus our efforts on understanding and prioritising good practices, we assess their feasibility for implementation and publish them here.

1 April 2019 in Journal of Translational Autoimmunity
Verified
Journal Article
Open access
SASigrid Aslaksen
Sigrid Aslaksen
AWAnette B. Wolff
Anette B. Wolff
MVMagnus Dehli Vigeland
Magnus Dehli Vigeland
LBLars Breivik
Lars Breivik
YSYing Sheng
Ying Sheng
EBEirik Bratland
Eirik Bratland
Autoimmune Addison's disease (AAD) is a classic organ-specific autoimmune disease characterized by an immune-mediated attack on the adrenal cortex. As most autoimmune diseases, AAD is believed to be caused by a combination of genetic and environmental factors, and probably interactions between the two. Persistent viral infections have been suggested to play a triggering role, by invoking inflammation and autoimmune destruction. The inability of clearing infections can be due to aberrations in innate immunity, including mutations in genes involved in the recognition of conserved microbial patterns. In a whole exome sequencing study of anonymized AAD patients, we discovered several rare variants predicted to be damaging in the gene encoding Toll-like receptor 3 (TLR3). TLR3 recognizes double stranded RNAs, and is therefore a major factor in antiviral defense. We here report the occurrence and functional characterization of five rare missense variants in TLR3 of patients with AAD. Most of these variants occurred together with a common TLR3 variant that has been associated with a wide range of immunopathologies. The biological implications of these variants on TLR3 function were evaluated in a cell-based assay, revealing a partial loss-of-function effect of three of the rare variants. In addition, rare mutations in other members of the TLR3-interferon (IFN) signaling pathway were detected in the AAD patients. Together, these findings indicate a potential role for TLR3 and downstream signaling proteins in the pathogenesis in a subset of AAD patients.

28 February 2025 in medRxiv
Verified
Preprint
Open access
PDF file
HAHaydee Artaza
Haydee Artaza
DTDivya Sri Priyanka Tallapragada
Divya Sri Priyanka Tallapragada
JMJanne Molnes
Janne Molnes
KLKsenia Lavrichenko
Ksenia Lavrichenko
AWAnette S.B. Wolff
Anette S.B. Wolff
SJStefan Johansson
Stefan Johansson
Technological advancements have significantly improved our understanding of Copy Number Variants (CNVs) and their role in disease. However, detecting CNVs in clinical diagnostics remains challenging, and important pathogenic CNVs may go undetected. This study systematically assessed the impact of rare, large, high-penetrance CNVs on pediatric diabetes and Maturity-onset Diabetes of the Young (MODY) in Norway. We analyzed data from the nationwide Norwegian Childhood Diabetes Registry (NCDR) covering 2002-2018 and the Norwegian MODY Registry (NMR) from 1997-2019. CNV detection was performed using the Illumina Infinium Global Screen Array-24 v2.0 on a total of 5,889 individuals and we compared the results to diagnostic records. Our findings indicate that 0.63% of the patients in the Norwegian MODY Registry and 0.09% in the Norwegian Childhood Diabetes Registry are attributable to established pathogenic large copy number deletions detectable by array genotyping. Notably, six of the 14 pathogenic deletions identified (in the HNF1B [n=3], HNF1A [n=2], or GATA4 genes [n=1]) had not been detected through standard diagnostic methods in the routine diagnostic screening. For these individuals, accurate molecular diagnoses have significant implications for personalized treatment and follow-up. We found no evidence suggesting a major role for additional rare CNVs beyond the already established pathogenic CNVs in MODY. In conclusion, while pathogenic CNVs are rare, they remain relevant for patients of the Norwegian nationwide diabetes registries. Expanding screening for MODY variants, specifically 17q12-HNF1B and HNF1A deletions, to a larger portion of the pediatric diabetes population should be considered.